SCHEMBL5260126

SCHEMBL5260126

O=C(O)Oc1cc(-c2ccncc2)n[nH]c1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 3/20 0.45
▸ GSK3A P49840 1/20 0.45
▸ DYRK1A Q13627 1/20 0.45
▸ HDAC3 O15379 1/20 0.40
▸ HDAC4 P56524 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC7 Q8WUI4 1/20 0.40
▸ HDAC2 Q92769 1/20 0.40
▸ HDAC10 Q969S8 1/20 0.40
▸ HDAC11 Q96DB2 1/20 0.40
▸ HDAC8 Q9BY41 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ HDAC9 Q9UKV0 1/20 0.40
▸ HDAC5 Q9UQL6 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ TACR3 P29371 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ ALPL P05186 6/20 0.38
▸ CA12 O43570 3/20 0.38
▸ CA9 Q16790 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7275010 0.81 TACR3 (0.42) TACR3ALPLCA12CA9RPA1
SCHEMBL2950654 0.77 GSK3B (0.53) GSK3BGSK3ADYRK1AHDAC3HDAC4
Hydrochloric Acid SCHEMBL11243227 0.76 GSK3B (0.52) GSK3BGSK3ADYRK1AHDAC3HDAC4
SCHEMBL5234548 0.75 MAPT (0.49) GSK3BTP53TACR3MAPK14ROCK2
SCHEMBL5229171 0.75 GSK3B (0.42) GSK3BGSK3ADYRK1AHDAC3HDAC4
SCHEMBL5232027 0.74 EPHX1 (0.51) GSK3BROCK2PRKCAGRK2
SCHEMBL5229174 0.73 GSK3B (0.43) GSK3BHDAC3HDAC4HDAC1HDAC7
SCHEMBL5243973 0.73 TSHR (0.48) GSK3BGSK3ADYRK1AMKNK2PIM1
SCHEMBL5231874 0.73 CASP1 (0.54) GSK3BROCK2
SCHEMBL11246270 0.73 CASP1 (0.54) GSK3BGSK3ADYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1725543-B1 4-BENZIMIDAZOL-2-YL-PYRIDAZINE-3-ONE-DERIVATIVES, PRODUCTION AND USE THEREOF IN MEDICAMENTS SANOFI AVENTIS DEUTSCHLAND (DE) 2007-11-28 — — EP disclosed
EP-1725543-A1 4-BENZIMIDAZOL-2-YL-PYRIDAZINE-3-ONE-DERIVATIVES, PRODUCTION AND USE THEREOF IN MEDICAMENTS Sanofi-Aventis Deutschland GmbH (DE) 2006-11-29 — — EP disclosed
WO-2005085230-A1 4-BENZIMIDAZOL-2-YL-PYRIDAZINE-3-ONE-DERIVATIVES, PRODUCTION AND USE THEREOF IN MEDICAMENTS SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2005-09-15 — — WO disclosed
Send feedback